BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND BCL7A, BCL7, 605, ENSG00000110987 AND Diagnosis
15 results:

  • 1. Radiomic combination of spatial and temporal features extracted from DCE-MRI for prostate cancer detection
    Fernandes CD; Mischi M; Wijkstra H; Barentsz JO; Heijmink SWTPJ; Turco S
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():3153-3156. PubMed ID: 34891910
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis.
    Piekarska K; Zacharczuk K; Wołkowicz T; Mokrzyś M; Wolaniuk N; Nowakowska M; Szempliński S; Dobruch J; Gierczyński R
    Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):81. PubMed ID: 34876123
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Incidence, prevalence, and outcomes of systemic malignancy with bone metastases.
    Jiang W; Rixiati Y; Zhao B; Li Y; Tang C; Liu J
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020915989. PubMed ID: 32634071
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer.
    Patel DN; Howard LE; De Hoedt AM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Klaassen ZW; Terris MK; Freedland SJ
    Cancer; 2020 Jul; 126(14):3274-3280. PubMed ID: 32374476
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Differences in Stage of cancer at diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading cancer Types.
    Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
    JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Detection of prostate cancer by Raman spectroscopy: A multivariate study on patients with normal and altered PSA values.
    Correia NA; Batista LTA; Nascimento RJM; Cangussú MCT; Crugeira PJL; Soares LGP; Silveira L; Pinheiro ALB
    J Photochem Photobiol B; 2020 Mar; 204():111801. PubMed ID: 31978674
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at prostate cancer diagnosis.
    Na R; Labbate C; Yu H; Shi Z; Fantus RJ; Wang CH; Andriole GL; Isaacs WB; Zheng SL; Helfand BT; Xu J
    JAMA Netw Open; 2019 Dec; 2(12):e1918145. PubMed ID: 31880795
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy.
    Narita S; Nomura K; Hatakeyama S; Takahashi M; Sakurai T; Kawamura S; Hoshi S; Ishida M; Kawaguchi T; Ishidoya S; Shimoda J; Sato H; Mitsuzuka K; Tochigi T; Tsuchiya N; Ohyama C; Arai Y; Nagashima K; Habuchi T
    Cancer Med; 2019 Nov; 8(15):6566-6577. PubMed ID: 31508900
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Reducing Unnecessary prostate Multiparametric Magnetic Resonance Imaging by Using Clinical Parameters to Predict Negative and Indeterminate Findings.
    Deniffel D; Zhang Y; Salinas E; Satkunasivam R; Khalvati F; Haider MA
    J Urol; 2020 Feb; 203(2):292-298. PubMed ID: 31479397
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Circulating microRNA signature for the diagnosis of very high-risk prostate cancer.
    Alhasan AH; Scott AW; Wu JJ; Feng G; Meeks JJ; Thaxton CS; Mirkin CA
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10655-60. PubMed ID: 27601638
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the prostate cancer Registry.
    Evans SM; Millar JL; Frydenberg M; Murphy DG; Davis ID; Spelman T; Bolton DM; Giles GG; Dean J; Costello AJ; Frauman AG; Kearns PA; Day L; Daniels C; McNeill JJ
    BJU Int; 2014 Nov; 114(5):680-90. PubMed ID: 24128010
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Blood donors: an ideal population to study the PSA value and the incidence of prostate cancer in healthy population.
    Fandella A; Borghesi M; Bertaccini A
    Arch Ital Urol Androl; 2011 Jun; 83(2):75-7. PubMed ID: 21826878
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease.
    Driver JA; Logroscino G; Buring JE; Gaziano JM; Kurth T
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1260-5. PubMed ID: 17548694
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. prostate brachytherapy: a descriptive analysis from CaPSURE.
    Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
    Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Associations of energy, fat, calcium, and vitamin D with prostate cancer risk.
    Kristal AR; Cohen JH; Qu P; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):719-25. PubMed ID: 12163324
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.